Search Finnegan

Conference

New Jersey Intellectual Property Law Association 39th Annual Pharmaceutical/Chemical Patent Practice Update New Jersey Intellectual Property Law Association 39th Annual Pharmaceutical/Chemical Patent Practice Update

Webinar

Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions

Federal Circuit IP Blog

Don’t Sleep on This: Federal Circuit Reverses Permanent Injunction Barring Clinical Trials and New Indications for NDA Don’t Sleep on This: Federal Circuit Reverses Permanent Injunction Barring Clinical Trials and New Indications for NDA

Articles

Strategies for Effectively Enhancing IP Value of Critical Assets after Teva v. Amneal and Other Recent Decisions Strategies for Effectively Enhancing IP Value of Critical Assets after Teva v. Amneal and Other Recent Decisions

Seminar

Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

Conference

4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA

At the PTAB Blog

Trends in PTAB Trials Involving Drug and Biologic Patents Trends in PTAB Trials Involving Drug and Biologic Patents

Articles

REMS Patents: Listability and Other Issues REMS Patents: Listability and Other Issues